3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-(942436-93-3)
- Name: 3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
- Synonyms:UNII-B9Z1OEH19D;AZD-6280;
- Molecular Formula:C20H22N4O3
- Molecular Weight:366.42
- CAS Registry Number:942436-93-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.942436-93-3 3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.942436-93-3 AZD-6280;942436-93-3
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.942436-93-3 3-CinnolinecarboxaMide, 4-aMino-8-(2,5-diMethoxyphenyl)-N-propyl-
Assay:98% Appearance:white powder Package:1mg Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Shanghai Yuanye Bio-Technology Co., Ltd. [
China (Mainland)] CAS No.942436-93-3 AZD-6280
Assay:98% Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 530141-72-1/Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)methoxy]-
- 753015-42-8/Pyridine, 3-[(1E)-2-(3R)-3-pyrrolidinylethenyl]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-
- 871484-32-1/Benzenebutanamide, 4-[[3-[(4-deoxy-4-fluoro-β-D-glucopyranosyl)oxy]-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-
- 710281-33-7/Benzoic acid, 2-[[[(1R,3S)-3-[[2-(3-methoxyphenyl)-5-methyl-4-oxazolyl]methoxy]cyclohexyl]oxy]methyl]-6-methyl-
- 519187-97-4/3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1)
- 165172-60-1/Thymidine, 2',3'-didehydro-3'-deoxy-, compd. with 1-methyl-2-pyrrolidinone (1:1) (9CI)
- 220099-91-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-
- 220100-81-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (9CI)
- 163680-80-6/7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-[1-(acetylamino)cyclopropyl]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)- (9CI)
- 630100-90-2/1-Piperazinecarboxylic acid, 4-cycloheptyl-, (2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-[(1E,3E,5R)-5-hydroxy-6-[(2R,3R)-3-[(1R,2S)-2-hydroxy-1-methylbutyl]-2-oxiranyl]-1,5-dimethyl-1,3-hexadien-1-yl]-3,7-dimethyl-12-oxooxacyclododec-4-en-6-yl ester
- 690270-65-6/Cytidine, 4'-C-azido-, 2',3',5'-tris(2-methylpropanoate), hydrochloride (1:1)
- 812647-80-6/Uridine, 4'-C-azido-, 2',3'-dibenzoate 5'-(3-chlorobenzoate) (9CI)
- 914361-45-8/L-Lysine, compd. with 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-1-methyl-2-[(phosphonooxy)methoxy]-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile and ethanol (1:1:1) (9CI)
- 936359-25-0/Benzoic acid, 2-[(3R)-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[[[1-(hydroxymethyl)cyclopropyl]methyl]thio]propyl]-, methyl ester
- 866920-24-3/1,2,4-Oxadiazol-5(2H)-one, 3-[2-chloro-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methoxy]phenyl]-
- 127660-04-2/4-Thiazoleacetic acid, 2-amino-α-(hydroxyimino)-, monosodium salt, (αZ)- (9CI)
- 1012065-72-3/Butanedioic acid, 2,3-bis(benzoyloxy)-, (2S,3S)-, compd. with ethyl (11bS)-2-amino-1,6,7,11b-tetrahydro-9,10-dimethoxy-4H-benzo[a]quinolizine-3-carboxylate (1:1)
- 1137606-74-6/2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 259793-88-9/6-bromo-3-hydroxypyrazine-2-carboxamide
- 942436-93-3/3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-
- 942437-37-8/3-Cinnolinecarboxamide, 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propyl-
- 912445-36-4/1H-Benzimidazole-7-carboxamide, 2-[(2S)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2)
- 952490-01-6/Propanoic acid, 2,2-dimethyl-, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl ester
- 948846-40-0/Butanedioic acid, 2,3-bis(benzoyloxy)-, (2S,3S)-, coMpd. with ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:)
- 1000164-36-2/Alanine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutaminyl-L-alanyl-L-alanyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-1-[(1,1-dimethylethoxy)carbonyl]-L-tryptophyl-L-leucyl-L-valyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-2-methyl-, 5-(1,1-dimethylethyl) ester
- 813452-14-1/2-Pyrrolidinone, 1-[(2S,3S,11bS)-2-amino-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-3-yl]-4-(fluoromethyl)-, hydrochloride (1:2), (4S)-
- 941685-39-8/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-
- 586414-48-4/Benzamide, 3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,4-dimethyl-, (-)-
- 540737-29-9/Tofacitinib citrate
- 1137917-12-4/Benzoic acid, 3-[[6-(ethylsulfonyl)-3-pyridinyl]oxy]-5-[(1S)-2-hydroxy-1-methylethoxy]-, compd. with 1,4-diazabicyclo[2.2.2]octane (2:1)